Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Renner

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Case Reports in Oncology|October 29, 2013
Successful Salvage Chemotherapy with FOLFIRINOX for Recurrent Mixed Acinar Cell Carcinoma and Ductal Adenocarcinoma of the Pancreas in an Adolescent PatientSarah Pfrommer, Achim Weber, Philipp Dutkowski, et al.
Arthritis and Rheumatism|May 12, 2012
Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritisSravan K Payeli, Simon Kollnberger, Osiris Marroquin Belaunzaran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2015
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)Christoph Mamot, Dirk Klingbiel, Felicitas Hitz, et al.
International Journal of Cancer|April 23, 2009
Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNgStefan Bauer, Jeannette C Oosterwijk-Wakka, Nicole Adrian, et al.
European Heart Journal|February 5, 2011
Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromataChad E Brokopp, Roman Schoenauer, Peter Richards, et al.
Swiss Medical Weekly|October 23, 2025
Updated recommendations for diagnosis and treatment of multiple myeloma in SwitzerlandMartina Bertschinger, Holger W Auner, Veronika Ballova, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2017
Mobilization of Hematopoietic Progenitor Cells with Standard- or Reduced-Dose Filgrastim after Vinorelbine in Multiple Myeloma Patients: A Randomized Prospective Single-Center Phase II StudyPanagiotis Samaras, Markus F Rütti, Burkhardt Seifert, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2009
Rational development of high-affinity T-cell receptor-like antibodiesGuillaume Stewart-Jones, Andreas Wadle, Anja Hombach, et al.
Swiss Medical Weekly|February 28, 2013
Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countriesJakob R Passweg, Helen Baldomero, Mario Bargetzi, et al.
Haematologica|February 9, 2012
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphomaChristoph Renner, Pier Luigi Zinzani, Rémy Gressin, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Case Reports in Oncology|October 29, 2013
Successful Salvage Chemotherapy with FOLFIRINOX for Recurrent Mixed Acinar Cell Carcinoma and Ductal Adenocarcinoma of the Pancreas in an Adolescent PatientSarah Pfrommer, Achim Weber, Philipp Dutkowski, et al.
Arthritis and Rheumatism|May 12, 2012
Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritisSravan K Payeli, Simon Kollnberger, Osiris Marroquin Belaunzaran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2015
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)Christoph Mamot, Dirk Klingbiel, Felicitas Hitz, et al.
International Journal of Cancer|April 23, 2009
Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNgStefan Bauer, Jeannette C Oosterwijk-Wakka, Nicole Adrian, et al.
European Heart Journal|February 5, 2011
Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromataChad E Brokopp, Roman Schoenauer, Peter Richards, et al.
Swiss Medical Weekly|October 23, 2025
Updated recommendations for diagnosis and treatment of multiple myeloma in SwitzerlandMartina Bertschinger, Holger W Auner, Veronika Ballova, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2017
Mobilization of Hematopoietic Progenitor Cells with Standard- or Reduced-Dose Filgrastim after Vinorelbine in Multiple Myeloma Patients: A Randomized Prospective Single-Center Phase II StudyPanagiotis Samaras, Markus F Rütti, Burkhardt Seifert, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2009
Rational development of high-affinity T-cell receptor-like antibodiesGuillaume Stewart-Jones, Andreas Wadle, Anja Hombach, et al.
Swiss Medical Weekly|February 28, 2013
Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countriesJakob R Passweg, Helen Baldomero, Mario Bargetzi, et al.
Haematologica|February 9, 2012
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphomaChristoph Renner, Pier Luigi Zinzani, Rémy Gressin, et al.
Pageof 13